D'Souza, A B <br/><br/>
Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.  [electronic resource] 

 -  Internal medicine journal  Sep 2006 
 - 600-3 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1445-5994 
<br/><br/><label>Standard No.: </label>10.1111/j.1445-5994.2006.01154.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Resorption--epidemiology<br/>Diphosphonates--therapeutic use<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Transplantation, Homologous<br/>Zoledronic Acid